DLD Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

DLD Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-220,000	Closed	-$15.9M	–	179
2020 Q4	$15.9M	Buy	+220,000	New	+$11.5M	0.45%	29

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.69B AUM 46.33% 1-Year Est. Return

DLD Asset Management's BEAT Position: Q1 2021 in Review

DLD Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 220,000 shares — an estimated $15.9M sold.

DLD Asset Management first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $15.9M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

DLD Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
DLD Asset Management sold 220,000 BioTelemetry, Inc. shares in Q1 2021, an estimated $15.9M.
DLD Asset Management first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
DLD Asset Management's BioTelemetry, Inc. position peaked at $15.9M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on DLD Asset Management's 13F filing for Q1 2021, filed 14 May 2021.